Archive for Urology News

Drug Before Surgery Clears Prostate Cancer

(MedPage Today) — A third of men with localized, high-risk prostate cancer achieved pathologic complete response or near-complete response following neoadjuvant therapy with abiraterone and an LHRH agonist, results of a preliminary clinical study showed.Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

Analogic Highlights Groundbreaking Quantum Technology at AUA Annual Meeting

Analogic Highlights Groundbreaking Quantum Technology at AUA Annual Meeting Analogic Corporation 17.05.2012 19:45 New BK Medical Ultrasound Systems With Quantum Technology Offer Exceptional Image Quality PEABODY, Mass., 2012-05-17 19:45 CEST (GLOBE NEWSWIRE) — Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, today announced that it will demonstrate its suite of new BK Medical branded ultrasound systems–the Flex Focus(tm) 500, Flex Focus 800, and Pro Focus(tm) UltraView 800 with the groundbreaking Quantum(tm) Technology–at the American Urological Association Annual Meeting, May 19-23, in Atlanta. Analogic’s BK Medical branded systems with Quantum Technology offer new features and solutions that provide clinicians a faster and easier way to maximize ultrasound performance, specifically in urology and renal imaging. Quantum Technology offers image quality advancements including improved contrast resolution, as well as new grayscale maps and new image pre-sets, making it easier and quicker to obtain the highest quality images.

Read More..

MDxHealth Provides First Quarter 2012 Business Update

IRVINE, Calif. & LIEGE, Belgium–(BUSINESS WIRE)– Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today issued its business update for the quarter ended March 31, 2012. Q1 2012 Highlights Material Events after the Reporting Period Yesterday, MDxHealth announced the launch of ConfirmMDx for Prostate Cancer in the United States.

Read More..

Need-to-know news and views for UB faculty and staff

Buffalo doctors share stories of Kashmir By ELLEN GOLDBAUM Published: May 14, 2012 A Kashmir native and UB clinical associate professor of urology has launched the Ladi Shah Project, Kashmirs first digital oral history archive. Khurshid A

Read More..

DGAP-News: Analogic Highlights Groundbreaking Quantum Technology at AUA Annual Meeting

Analogic Corporation 17.05.2012 19:45 New BK Medical Ultrasound Systems With Quantum Technology Offer Exceptional Image Quality PEABODY, Mass., 2012-05-17 19:45 CEST (GLOBE NEWSWIRE) — Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, today announced that it will…

Read More..

Mount Sinai Prostate Cancer Surgeon Performs 4000th Robotic-Assisted Radical Prostatectomy

David B. Samadi, MD, the Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, has achieved the milestone of performing his 4000th robotic-assisted laparoscopic prostatectomy.New York (PRWEB) May 15, 2012 This spring, David B.

Read More..

Chemo Before Surgery Clears Prostate Cancer

(MedPage Today) — A third of men with localized, high-risk prostate cancer achieved pathologic complete response or near-complete response following neoadjuvant therapy with abiraterone and an LHRH agonist, results of a preliminary clinical study showed.Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

Mauna Kea Technologies Announces Highlights of 4th Annual International Conference OF Cellvizio® Users (ICCU)

Regulatory News: Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA, FR0010609263), the leader in the endomicroscopy market, today announced highlights of the Fourth Annual International Conference of Cellvizio Users (ICCU), which took place last month in Rome. Bertrand Napolon, MD, a specialist in gastroenterology at Jean Mermoz Private Hospital in Lyon, France, and Kenneth J

Read More..

Predicting Risk Of Death In End-Stage Kidney Disease, New Equation More Accurate

Editor’s Choice Main Category: Urology / Nephrology Article Date: 10 May 2012 – 11:00 PDT Current Article Ratings: Glomerular filtration rate (GRF) is a test used to determine whether the kidneys are functioning properly and is used in the diagnosis of chronic kidney disease (CKD). In addition, GRF is an independent predictor of all-cause and cardiovascular mortality and renal failure. According to clinical guidelines, physicians are advised to report estimated GFR when measuring serum creatinine levels

Read More..

The Journal of Urology® wins 2012 ASAE Gold Circle Award

Public release date: 10-May-2012 [ | E-mail | Share ] Contact: Linda Gruner l.gruner@elsevier.com 212-633-3923 Elsevier New York, May 10, 2012 The Journal of Urology , the official journal of the American Urological Association (AUA), has won the 2012 ASAE Gold Circle Award (Peer-Reviewed Journal category). Michael Sheppard, CPA, CAE, Executive Director, AUA comments, “Earlier this year, the AUA nominated The Journal of Urology for an ASAE Gold Circle Award (Peer-Reviewed Journal category).

Read More..

Dendreon Reports Net PROVENGE Product Revenues of $82 Million, Achieved 6.5% Quarter-Over-Quarter Growth

SEATTLE–(BUSINESS WIRE)– May 7, 2012–Dendreon Corporation (Nasdaq:DNDN – News) today reported results for the quarter ended March 31, 2012. Net product revenue for the quarter was $82.0 million compared to $27.0 million for the quarter ended March 31, 2011. Net loss in the first quarter of 2012 was $103.9 million or $0.70 per share, compared to a net loss of $112.8 million, or $0.78 per share, for the same period in 2011

Read More..

Long Island doctor calls prostate study a sham

by Gregory Zeller Published: May 9, 2012 Tags: Advanced Urology Centers of New York, American Cancer Society, American Clinical Laboratory Association, College of American Pathology, Health Care, North Shore-Long Island Jewish Health System, prostate, prostate screenings, Warren Buffet $119 A Great Value! You have clicked on a link to information that is exclusive to LIBN subscribers. Already a paid subscriber but not registered for online access yet

Read More..

Limit PSA Tests to Younger Men, These Docs Say (CME/CE)

(MedPage Today) — Healthy younger men should be screened regularly for prostate cancer using prostate-specific antigen testing, but older men in poor health should not be, researchers suggested.Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

Lab Notes: Skin Immune Cells Swing Both Ways

(MedPage Today) — Langerhans cells in the skin may suppress excess immune activity or direct attacks on invaders, depending on which is needed. Also this week: a possible common target for multiple pathogens.Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

Extensive Tests Not Needed for Incontinence Surgery (CME/CE)

(MedPage Today) — For uncomplicated stress urinary incontinence, urodynamic testing doesn’t add much to the basic office evaluation, a clinical trial determined.Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

Review of Strategic Alternatives

DUBLIN, April 30, 2012 (GLOBE NEWSWIRE) — Further to media speculation, the Board of Warner Chilcott plc (WCRX – News) confirmed today that it is conducting a process to explore a broad range of strategic alternatives to enhance shareholder value, which include preliminary discussions with potential offerors. These discussions are at a preliminary stage and may or may not lead to an offer for the Company. The Company does not intend to disclose further developments regarding the process unless and until its Board has approved a specific course of action, or it otherwise deems further disclosure is appropriate or required.

Read More..

Poorer Quality of Life for Gay Men and Minorities After Prostate Cancer Treatment: What Are We Missing?

Newswise PHILADELPHIA To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men choose a more-suitable treatment plan, researchers from Thomas Jefferson University Hospital conclude in a literature review published May 1 in Nature Reviews Urology.

Read More..

Theragenics to Report First Quarter 2012 Financial Results Thursday, May 10

BUFORD, Ga.–(BUSINESS WIRE)– Theragenics Corporation (NYSE: TGX – News) expects to release first quarter 2012 financial results before the market opens on May 10, 2012. Following this release, the Company will host a conference call at 11:00 a.m.

Read More..

FDA Rejects Bone Drug Bid for Metastasis Prevention

WASHINGTON (MedPage Today) — The FDA has turned down an application to expand the indications for denosumab to include prevention of bone metastases in men with castration-resistant prostate cancer.Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

New Drug for ED Wins FDA Approval

WASHINGTON (MedPage Today) — The PDE-5 inhibitor class of drugs for erectile dysfunction gained its first new member in a decade with the FDA approval of avanafil (Stendra).Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

Docs May Resist PSA Screening Recommendations (CME/CE)

(MedPage Today) — Breaking the habit of prostate cancer screening may take more than a simple recommendation from a prevention task force, two studies suggest.Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

Robotic Surgery Dominant in Prostate Cancer (CME/CE, with audio)

(MedPage Today) — Fueled in part by superior outcomes, robotic-assisted radical prostatectomy has surpassed open surgery as the predominant surgical approach to localized prostate cancer, analysis of a national database showed.Source:http://www.medpagetoday.com/rss/Urology.xml

Read More..

Bard Announces First Quarter Results

MURRAY HILL, N.J.–(BUSINESS WIRE)– C. R. Bard, Inc.

Read More..

Plethora Solutions – Change of Registered Office

24 April 2012 Plethora Solutions Holdings PLC (“Plethora” or the “Company”) Change of Registered Office The Company announces that, with immediate effect, its registered address has changed to: 1st Floor, St Andrew’s House, 18-20 St Andrew Street, London, EC4A 3AG All telephone and fax numbers remain the same.

Read More..

Males With Mutated BRCA1 Breast Cancer Gene Have Higher Prostate Cancer Risk

Editor’s Choice Academic Journal Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology;Genetics Article Date: 23 Apr 2012 – 13:00 PDT email to a friend printer friendly opinions Current Article Ratings: 3 (1 votes) 3 (1 votes) Men with the mutated BRCA1 gene are also more susceptible to the very aggressive form of prostate cancer. The authors explained that hopefully, their findings may have an impact on the potential screening and treatment procedures for patients with prostate cancer

Read More..